Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312196656> ?p ?o ?g. }
- W4312196656 abstract "Abstract In early 2022, a cluster of Monkeypox (now termed MPOX) virus (MPXV) cases were identified within the UK with no prior travel history to MPXV-endemic regions, suggesting localised transmission of MPXV within the UK. Subsequently, cases were identified in several other non-endemic countries and currently exceed 80,000 worldwide, primarily affecting gay, bisexual, and other men who have sex with men. Public health agencies worldwide have offered the IMVANEX Smallpox vaccination to these individuals to provide protection and limit the spread of MPXV. We have developed a comprehensive array of ELISA assays to study poxvirus-induced antibodies, utilising 24 MPXV and 3 Vaccinia virus (VACV) recombinant antigens. Panels of serum samples from individuals with one, two, or three doses of IMVANEX or ACAM2000 (Modified Vaccinia Ankara (MVA)) vaccination, and those with prior MPOX infection were tested against these antigens, with Pearson correlation, principal component analysis and receiver operator curve statistics used to further elucidate antigenic responses to pox-virus infection. Furthermore, using our data, we demonstrated the development of a pooled antigen ELISA that can reliably detect antibody responses induced by Smallpox vaccination or MPXV infection. Using diverse poxvirus antigen ELISAs, we observe that one dose of Smallpox vaccination induces a low number of antibodies, primarily against MPXV B2, with a second dose inducing considerably higher antibody responses against B2R but also to other MPXV antigens such as B5, E8, M1, and A35. Prior MPXV infection, both Clades IIa and IIb, induce variable responses, but similarly induce antibody responses to poxvirus antigens observed in Smallpox-vaccinated individuals, and additionally responses to MPXV A27, A29 and H3. Principal component and Pearson correlation matrix identified MPXV A27 as a differential between IMVANEX and MPOX-infected individuals, whilst MPXV M1 (VACV L1) is likely a serological marker of IMVANEX-vaccination. When using recombinant MPXV/VACV protein homologues, we also observe a difference in antigen binding, with variability based on the individual’s originating infection/vaccination. Using a pooled-antigen ELISA, we also demonstrate a sensitivity of 97.14% (95% CI:91.93-99.22) and specificity of 98.23% (96.67-99.07) in detecting poxvirus antibodies with applicability to measuring longitudinal antibody responses post-vaccination/post-MPXV infection. Here, we show that both MPXV-infected or Smallpox-vaccinated individuals mount antibodies able to bind a diverse but core set of poxvirus antigens, with implications for future vaccine (e.g., mRNA-based) and therapeutic (e.g., monoclonal antibodies) targets. We identify low levels of antibodies observed in those post dose one IMVANEX, but considerably higher levels of antibodies post dose two. We also demonstrate that homologous VACV and MPXV antigens may offer a mechanism for discriminating between vaccinated and MPXV-infected individuals through differential binding, aiding in serosurveillance and future immunology studies." @default.
- W4312196656 created "2023-01-04" @default.
- W4312196656 creator A5005102502 @default.
- W4312196656 creator A5005637137 @default.
- W4312196656 creator A5008021864 @default.
- W4312196656 creator A5010837677 @default.
- W4312196656 creator A5010911519 @default.
- W4312196656 creator A5014013049 @default.
- W4312196656 creator A5017875403 @default.
- W4312196656 creator A5021855123 @default.
- W4312196656 creator A5022186162 @default.
- W4312196656 creator A5024115924 @default.
- W4312196656 creator A5024906484 @default.
- W4312196656 creator A5026192106 @default.
- W4312196656 creator A5032895526 @default.
- W4312196656 creator A5035331876 @default.
- W4312196656 creator A5040700370 @default.
- W4312196656 creator A5040702981 @default.
- W4312196656 creator A5041924340 @default.
- W4312196656 creator A5049567525 @default.
- W4312196656 creator A5054166853 @default.
- W4312196656 creator A5062161024 @default.
- W4312196656 creator A5065165564 @default.
- W4312196656 creator A5065624311 @default.
- W4312196656 creator A5066955321 @default.
- W4312196656 creator A5068922045 @default.
- W4312196656 creator A5077996137 @default.
- W4312196656 creator A5085766761 @default.
- W4312196656 creator A5085847806 @default.
- W4312196656 date "2022-12-26" @default.
- W4312196656 modified "2023-10-15" @default.
- W4312196656 title "Analogous humoral antigen recognition between Monkeypox-infected and Smallpox-vaccinated individuals" @default.
- W4312196656 cites W1577214437 @default.
- W4312196656 cites W1905430348 @default.
- W4312196656 cites W1970129342 @default.
- W4312196656 cites W1970190275 @default.
- W4312196656 cites W1970263819 @default.
- W4312196656 cites W1975646238 @default.
- W4312196656 cites W1977189837 @default.
- W4312196656 cites W1981328083 @default.
- W4312196656 cites W1981640984 @default.
- W4312196656 cites W1982058761 @default.
- W4312196656 cites W1984263551 @default.
- W4312196656 cites W1986997318 @default.
- W4312196656 cites W2009065354 @default.
- W4312196656 cites W2014840151 @default.
- W4312196656 cites W2026129690 @default.
- W4312196656 cites W2027765075 @default.
- W4312196656 cites W2037526992 @default.
- W4312196656 cites W2038166412 @default.
- W4312196656 cites W2042370230 @default.
- W4312196656 cites W2057969131 @default.
- W4312196656 cites W2060364473 @default.
- W4312196656 cites W2078406439 @default.
- W4312196656 cites W2086240204 @default.
- W4312196656 cites W2087483191 @default.
- W4312196656 cites W2093462119 @default.
- W4312196656 cites W2093937338 @default.
- W4312196656 cites W2108522791 @default.
- W4312196656 cites W2109977446 @default.
- W4312196656 cites W2112575263 @default.
- W4312196656 cites W2122444175 @default.
- W4312196656 cites W2128033630 @default.
- W4312196656 cites W2129485336 @default.
- W4312196656 cites W2134161715 @default.
- W4312196656 cites W2145410812 @default.
- W4312196656 cites W2153210428 @default.
- W4312196656 cites W2153295129 @default.
- W4312196656 cites W2157220423 @default.
- W4312196656 cites W2158437004 @default.
- W4312196656 cites W2164828578 @default.
- W4312196656 cites W2169015842 @default.
- W4312196656 cites W2532821028 @default.
- W4312196656 cites W2762164466 @default.
- W4312196656 cites W2946710272 @default.
- W4312196656 cites W3005209336 @default.
- W4312196656 cites W4225689052 @default.
- W4312196656 cites W4234185093 @default.
- W4312196656 cites W4283360071 @default.
- W4312196656 cites W4296285989 @default.
- W4312196656 cites W4306721676 @default.
- W4312196656 cites W4306902108 @default.
- W4312196656 cites W4307774280 @default.
- W4312196656 cites W4309866984 @default.
- W4312196656 cites W4311452547 @default.
- W4312196656 cites W4311769374 @default.
- W4312196656 doi "https://doi.org/10.1101/2022.12.22.22283648" @default.
- W4312196656 hasPublicationYear "2022" @default.
- W4312196656 type Work @default.
- W4312196656 citedByCount "0" @default.
- W4312196656 crossrefType "posted-content" @default.
- W4312196656 hasAuthorship W4312196656A5005102502 @default.
- W4312196656 hasAuthorship W4312196656A5005637137 @default.
- W4312196656 hasAuthorship W4312196656A5008021864 @default.
- W4312196656 hasAuthorship W4312196656A5010837677 @default.
- W4312196656 hasAuthorship W4312196656A5010911519 @default.
- W4312196656 hasAuthorship W4312196656A5014013049 @default.
- W4312196656 hasAuthorship W4312196656A5017875403 @default.
- W4312196656 hasAuthorship W4312196656A5021855123 @default.
- W4312196656 hasAuthorship W4312196656A5022186162 @default.